Health benefits of traditional corn, beans, and pumpkin: In vitro studies for hyperglycemia and hypertension management

Journal of Medicinal Food

Volumn 10, Issue 2, 2007, Pages 266-275

  Kwon, Y I ^a   Apostolidis, E ^a   Kim, Y C ^a   Shetty, K ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

amylase inhibitor; glucosidase inhibitor; Angiotensin I converting enzyme inhibitor; Beans; Corn; Hypertension; Non insulin dependent diabetes mellitus; Phenolic phytochemicals; Pumpkin; Traditional diet

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; AMYLASE INHIBITOR; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; PHENOL DERIVATIVE; PLANT EXTRACT;

ARTICLE; BEAN; CORN; DIETARY INTAKE; ENZYME ASSAY; FEEDING BEHAVIOR; FOOD COMPOSITION; FOOD QUALITY; HYPERGLYCEMIA; HYPERTENSION; IN VITRO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PHYTOCHEMISTRY; PRIORITY JOURNAL; PUMPKIN;

AMYLASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; CUCURBITA; ENZYME INHIBITORS; FABACEAE; GLUCOSIDASES; HYPERGLYCEMIA; HYPERTENSION; PHENOLS; PLANT EXTRACTS; RABBITS; RATS; SEEDS; SWINE; ZEA MAYS;

ZEA MAYS;

EID: 34547113083     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.234     Document Type: Article

References (42)

1. Jackson Y: Nutrition in American Indian health: past, present and future. J Am Diet Assoc 1986;86:1561-1565.
2. Young TK: Diabetes mellitus among native Americans in Canada and the United States. An epidemiological review. Am J Hum Biol 1993;35:399-413.
3. Story M, Evans M, Fabsitz RR, Clay TE, Rock BH, Broussard B: The epidemic of obesity in American Indian communities and the need for childhood obesity-prevention programs. Am J Clin Nutr 1999;69(Suppl):747S-754S.
4. Harriet VK, Olivier P: Dietary change and traditional food systems of indigenous peoples. Annu Rev Nutr 1996;16:417-442.
5. Harris MI, Zimmer P: Classification of diabetes mellitus and other categories of glucose intolerance. In: International Textbook of Diabetes Mellitus (Albert KGGM, De Fronzo RA, Keen H, Zimmer P, eds.), John Wiley, London, 1992, pp. 3-18.
6. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
7. Kawamura M, Heinecke JW, Chait A: Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide dependent pathway. J Clin Invest 1994;94:771-778.
8. Brownlee M: The pathobiology of diabetic complications. Diabetes 2005;54:1615-1625.
9. Kaiser N, Sasson S, Feener EP, Boukobza N, Higashi S, Moller DE: Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 1993;42:80-89.
10. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 1995;96:1802-1814.
11. Lee AY, Chung SS: Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 1999;13:23-30.
12. Puls W, Keup U, Krause H, Thomas PG, Hoffmeister F: Glucosidase inhibition: a new approach to the treatment of diabetes, obesity and hyperlipoproteinemia. Naturwissen Schaften 1977;64:536-537.
13. Horii S, Fukasse K, Matsuo T, Kameda K, Asano N, Masui Y: Synthesis and α-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potent oral antidiabetic agents. J Med Chem 1987;29:1038-1046.
14. Bischoff H, Puls W, Krause HP, Schutt H, Thomas G: Pharmacological properties of the novel glucosidase inhibitors BAY m 1099 (miglitol) and BAY o 1248. Diabetes Res Clin Pract 1985;1:53-57.
15. Puls W, Keup U: Metabolic studies with an amylase. In: Recent Advances in Obesity Research, Vol. 3 (Howard A, ed.), Newman, London, 1975, p. 391.
16. Bischoff H: Pharmacology of glucosidase inhibitor. Eur J Clin Invest 1994;24:3-10.
17. Kwon Y-I, Vattem DV, Shetty K: Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac J Clin Nutr 2006;15:107-118.
18. Skeggs LT, Khan JR, Shumway NP: The preparation and function of the hypertension-converting enzyme. J Exp Med 1956;103:295-299.
19. Lieberman J: Elevation of serum angiotensin I-converting enzyme (ACE) level in sarcoidiosis. Am J Med 1975;59:365-372.
20. Erdos EG, Skidgel RA: The angiotensin I-converting enzyme. Lab Invest 1987;56:345-348.
21. Johnston JI, Franz V: Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens 1992;10:13-26.
22. Suda I, Oki T, Masuda M, Nishiba Y, Furuta S, Matsugano K, Sugita K, Tarahara N: Direct absorption of acylated anthocyanin in purple-fleshed sweet potato into rats. J Agric Food Chem 2002;50:1672-1676.
23. Suda I, Oki T, Masuda M, Kobayashi M, Nishiba Y, Furuta S: Physiological functionality of purple-fleshed sweet potato containing anthocyanins and their utilization in foods. Jpn Agric Res Q 2003;37:167-173.
24. Mann J: Secondary metabolism. In: Oxford Chemistry Series, Clarendon Press, Oxford, 1978, p. 116.
25. Bravo L: Phenolic phytochemicals: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998;56:317-333.
26. Crozier A, Burns J, Aziz AA, Stewart AJ, Rabiaz HS, Jenkins GI, Edwards CA, Lean MEJ: Antioxidant flavonols from fruits, vegetables and beverages: measurements and bioavailability. Biol Res 2000;33:79-88.
27. Shetty K: Biotechnology to harness the benefits of dietary phenolics; focus on Lamiaceae. Asia Pac J Clin Nutr 1997;6:162-171.
28. Shetty K: Phytochemicals: biotechnology of phenolic phytochemicals for food preservatives and functional food applications. In: Encyclopedia of Food Science and Technology, 2nd ed. (Francis FJ, ed.), Wiley, New York, 1999, pp. 1901-1909.
29. Shetty K: Biosynthesis of rosmarinic acid and applications in medicine. J Herbs Species Med Plants 2001;8:161-181.
30. Shetty K, Labbe RL: Foodborne pathogens, health and role dietary phytochemicals. Asia Pac J Clin Nutr 1998;7:270-276.
31. Block G, Patterson B, Subar A: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992;18:1-29.
32. Serdula MK, Byers MH, Simoes E, Mendlein ML, Coates RJ: The association between fruit and vegetable intake and chronic disease risk factors. Epidemiology 1996;7:161-165.
33. U.S. Department of Agriculture: Mypyramid, inside the pyramid. http://www.mypyramid.gov/pyramid/grains.html (accessed August 2006).
34. American Diabetes Association: Using the diabetes pyramid, http://www.diabetes.org/nutrition-and-recipes/nutrition/foodpyramid.jsp (accessed August 2006).
35. Sauer J, Kaplan L: Canavalia beans American prehistory. Am Antiquity 1969;34:417-424.
36. Shetty K, Curtis OF, Levin RE, Wikowsky R, Ang W: Prevention of verification associated with in vitro shoot culture of oregano (Origanum vulgare) by Pseudomonas spp. J Plant Physiol 1995;147:447-451.
37. Worthington V, ed.: Alpha amylase. In: Worthington Enzyme Manual, Worthington Biochemical Corp., Freehold, NJ, 1993, pp. 36-41.
38. Worthington V, ed.: Maltase-α-glucosidase. In: Worthington Enzyme Manual, Worthington Biochemical Corp., Freehold, NJ, 1993, p. 261.
39. McCue P, Kwon Y-I, Shetty K: Anti-amylase, anti-glucosidase and anti-angiotensin I-converting enzyme potential of selected foods. J Food Biochem 2005;29:278-294.
40. Englyst HN, Hay S, Macfarkane GT: Polysaccharide break-down by mixed populations of human faecal bacteria. FEMS Microbiol Ecol 1987;95:163-171.
41. Weaver GA, Tangel CT, Krause JA, Parfitt MM, Jenkins PL, Rader JM, Lewis BA, Miller TL, Wolin MJ: Acarbose enhances human colonic butyrate. J Nutr 1997;127:717-723.
42. Lo WM, Li-Chan EC: Angiotensin converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. J Agric Food Chem 2005;53:3369-3376.